Similar Items: Cerebrospinal fluid NPTX2/p‐tau ratio as a biomarker for cognitive decline in neurodegenerative diseases
- Elevated sclerostin levels in cerebrospinal fluid are associated with cognitive impairment in the Alzheimer's disease continuum
- Enlarged perivascular spaces in subcortical white matter are linked to amyloid–tau depositions and cognitive decline: Data from a memory clinic in Thailand
- A potential multimodal biomarker – cognitive signature associated with the conversion from subjective cognitive decline to mild cognitive impairment
- Associations of plasma p‐Tau217 with cognitive domain performance in clinically unimpaired participants: Evidence from HABS‐HD
- Cerebrovascular reactivity and plasma p‐tau181 in Alzheimer's disease: Insights into APOE‐related vascular phenotypes
- Aβ‐ and tau‐associated neuroinflammatory signatures in Alzheimer's disease